Travere Therapeutics, Inc. (0001438533) (Filer) — SEC 8-K Filing
HealthcareOther
Travere Therapeutics
May 11, 2026
Solis Mammography Stake Sale Announced by PE
Announced
HealthcareOther
Deal Overview
A private equity firm announced the sale of an ownership stake in Solis Mammography, a healthcare diagnostics-imaging business. The transaction is categorized as “other” and is listed as announced.
The excerpt contains no deal price or consideration details, and no additional transaction terms are stated beyond the ownership-stake sale framing.
Key Details
- Target
- Solis Mammography
Source
Read full article on news.google.comvia Google News - healthcare acquisition PE · January 25, 2026
Powered by Tentt
Source healthcare deals for your firm
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Related Deals
Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
HealthcareOther
Pharvaris
May 11, 2026
A Cancer Driven by Ultra-Rare Mutation Gets Its First FDA-Approved Therapy
HealthcareDivestiture
Partner Therapeutics→Bizengri (bispecific antibody)
May 11, 2026
Oregon ASC to close after acquisition collapses amid state review
HealthcareOregonOther
The Surgery Center of Southern Oregon
May 11, 2026
Mobia Medical CEO eyes large market for stroke rehab
HealthcareCaliforniaOther
Mobia Medical
May 11, 2026